GleamWall
中文EN

IMCC IM Cannabis Corp. IFRS

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1792030 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY1.3%
TTM net income YoY-6.9%
TTM EPS YoY—
Revenue 3-yr CAGR0.2%
Net income 3-yr CAGR—

Margins

Gross margin17.7%
Operating margin-21.2%
Net margin-20.7%
FCF margin8.6%
EBITDA margin—

Returns

ROE-1,496.2%
ROA-31.9%
ROIC (approx.)-63.6%
Asset turnover1.54x

Leverage & solvency

Liabilities / assets111.4%
Debt / equity—
Current ratio0.67x
Interest coverage-3.31x

Cash quality & payout

Operating cash flow / net income-0.42x
Accruals ratio-45.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD FY20252025-12-31FY20242024-12-31
Income statement
Revenue54.73M54.03M
Cost of revenue45.05M45.58M
Gross profit9.69M8.45M
SG&A expense9.52M8.02M
Operating income-11.59M-10.23M
Interest expense3.50M4.77M
Pretax income-11.66M-12.79M
Income tax92,000-1.02M
Net income-11.32M-10.59M
EPS (basic)—-4.51
EPS (diluted)—-4.51
Balance sheet
Cash & equivalents2.73M863,000
Receivables4.32M5.42M
Inventory4.27M3.21M
Current assets22.74M23.36M
PP&E, netmay include right-of-use assets (IFRS)3.71M3.73M
Goodwill1.89M6.68M
Intangibles1.22M3.33M
Total assets31.74M39.19M
Current liabilities34.01M34.92M
Short-term debt14.33M15.14M
Long-term debt936,000466,000
Total debt15.27M15.61M
Total liabilities35.35M36.04M
Shareholders' equity-3.73M5.24M
Net debt12.54M14.75M
Shares outstanding5.89M3.09M
Cash flow statement
Operating cash flow4.72M-1.08M
Capital expenditure13,000156,000
Free cash flow4.70M-1.23M
Investing cash flow-531,000-470,000
Financing cash flow1.15M3.83M
Stock-based compensation14,000369,000

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.